English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
OBI-902 has been granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma
Nov 17, 2025 20:00 HKT
'iRad Hospital' and 'Hong Kong Sanatorium & Hospital' Partner to Launch Premium Cross-Border Medical Concierge Services
Nov 17, 2025 16:54 HKT
卓智医院与香港养和医院携手推出优质跨境医疗礼宾服务
Nov 17, 2025 16:54 HKT
卓智醫院與香港養和醫院攜手推出優質跨境醫療禮賓服務
Nov 17, 2025 16:54 HKT
康诺思腾(Cornerstone Robotics)完成新一轮约2亿美元超募融资
Nov 13, 2025 20:38 HKT
Cornerstone Robotics Closes Oversubscribed New Financing Round of Approximately US$200 million
Nov 11, 2025 11:38 HKT
Bright China 2025: Airdoc PBM Vision Rehabilitation Device Clinical Research Data Release
Nov 11, 2025 09:22 HKT
Bright China 2025:鷹瞳PBM視力康復儀臨牀研究數據發佈
Nov 11, 2025 09:20 HKT
Bright China 2025:鹰瞳PBM视力康复仪临床研究数据发布
Nov 11, 2025 09:20 HKT
康諾思騰(Cornerstone Robotics)完成新一輪約2億美元超募融資
Nov 10, 2025 08:46 HKT
Market Value Lower Than Cash Assets? It's Time to Reevaluate NIVF
Nov 06, 2025 21:36 HKT
「非洲消費品製造第一股」招股進行中:頂流機構加持
Nov 04, 2025 17:13 HKT
「非洲消费品制造第一股」招股进行中:顶流机构加持
Nov 04, 2025 17:13 HKT
TruMerit 公司彼得·普雷佐西当选为联合国咨商地位非政府组织会议主席
Oct 31, 2025 10:00 HKT
TruMerit 公司彼得·普雷佐西當選為聯合國諮商地位非政府組織會議主席
Oct 31, 2025 10:00 HKT
全球首創抗炎代謝調節劑HTD1801完成2型糖尿病III期臨床研究 展現持續52周的綜合獲益與安全性優勢
Oct 31, 2025 08:30 HKT
???????????HTD1801??2????III????? ????52????????????
Oct 31, 2025 08:30 HKT
TruMerit's Peter Preziosi Elected President of the Conference of NGOs in Consultative Relationship With the United Nations
Oct 31, 2025 04:00 HKT
CMS (867.HK; 8A8.SG) NDA for AD Indication of Long-acting Anti-IL-4Ra Humanized Monoclonal Antibody Injection MG-K10 Accepted in China
Oct 30, 2025 20:00 HKT
康哲药业(867.HK;8A8.SG)长效抗IL-4Rα人源化单抗注射液MG-K10特应性皮炎适应症中国NDA已获受理
Oct 30, 2025 18:27 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: